GC62329
VPC-14449
Also known as 4-[4-(2,4-dibromoimidazol-1-yl)-1,3-thiazol-2-yl]morpholine
VPC-14449 is a potent and selective inhibitor of the DNA-binding domain of the androgen receptor (AR-DBD), with IC50 of 0·34 μM for full-length human AR· VPC-14449 reduces the ability of full-length AR as well as AR variants to interact with chromatin· VPC-14449 can be used for the research of prostate cancer
ChemicalCAS1621375-32-3MW394.09FormulaC10H10Br2N4OS
- CAS number
- 1621375-32-3
- Molecular weight
- 394.09
- Formula
- C10H10Br2N4OS
- Solubility
- DMSO ： 125 mg/mL (317·19 mM; Need ultrasonic)
- InChIKey
- AZLNRGRZOLVWRX-UHFFFAOYSA-N
- Catalogue number
- GC62329
- Brand
- GLPBIO
Computed properties PubChem CID 135150480 · XLogP 3.2 · TPSA 71.4 Ų · H-bond donors 0
- XLogP
- 3.2
- TPSA
- 71.4 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 18
SMILES C1COCCN1C2=NC(=CS2)N3C=C(N=C3Br)Br
Computed descriptors from PubChem (CID 135150480), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il